Doctor profile · Federal record
Dr. Michael Gibson, M.D.
Interventional Pain Medicine Physician (CMS: Interventional Pain Management) · Anesthesiology Physician · Pain Medicine (Anesthesiology) Physician · Pain Medicine (Physical Medicine & Rehabilitation) Physician · Pain Medicine (Psychiatry & Neurology) Physician · Pain Medicine Physician · Hoover, AL
- NPI 1013068881
- Accepts Medicare
- MIPS 76.8 / 100 · 2023
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4515 Southlake Pkwy Ste 200
Hoover, AL 352443319
(205) 313-7246
fax (205) 939-1911 - Mailing address
-
4515 Southlake Pkwy, Suite 200
Hoover, AL 352443319
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- October 31, 2017
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 208VP0014X — NUCC code
- State license (1)
- Alabama #17424
- Medicaid
- AL #529502690
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1013068881. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,220
Distinct HCPCS
10
Medicare allowed
$423,529
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 3,238 | 114 | $0 | |
80307 |
Testing for presence of drug, by chemistry analyzers | 917 | 274 | $59 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 819 | 264 | $80 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 802 | 249 | $112 | |
G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 745 | 228 | $150 | |
G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 123 | 46 | $187 | |
80053 |
Blood test, comprehensive group of blood chemicals | 67 | 67 | $10 | |
64483 |
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 58 | 46 | $304 | |
82947 |
Blood glucose (sugar) level | 54 | 26 | $3 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 53 | 52 | $7 |
In context: peer comparison
Among 3 peers in Hoover Interventional Pain Medicine Physician, average services per provider: 219. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$956
Transactions
53
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pfizer INC. | 14 | $228.78 | |
| Forte Bio-Pharma LLC | 12 | $159.40 | |
| Collegium Pharmaceutical, INC. | 6 | $112.48 | |
| Boston Scientific Corporation | 5 | $109.67 | |
| Spr Therapeutics, INC | 4 | $104.08 | |
| Scilex Pharmaceuticals INC. | 3 | $58.67 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | 3 | $51.78 | |
| Averitas Pharma INC. | 2 | $47.79 | |
| Abbvie INC. | 1 | $29.78 | |
| Lundbeck LLC | 1 | $19.83 | |
| Vertex Pharmaceuticals Incorporated | 1 | $18.71 | |
| Idorsia Pharmaceuticals US INC | 1 | $14.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
12,807
Patients
1,928
Total drug cost
$508,371
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 2,424 | 337 | $169,541 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 2,258 | 322 | $72,216 |
| Gabapentin | Generic | 1,641 | 257 | $29,344 |
| Tizanidine Hcl | Generic | 1,241 | 209 | $16,135 |
| Oxycodone Hcl | Generic | 1,090 | 142 | $34,163 |
| Morphine Sulfate ER (Morphine Sulfate) | Brand | 769 | 104 | $45,255 |
| Fentanyl | Generic | 538 | 67 | $78,591 |
| Methadone Hcl | Generic | 529 | 53 | $18,037 |
| Methocarbamol | Generic | 394 | 81 | $8,516 |
| Trazodone Hcl | Generic | 385 | 66 | $3,254 |
Frequently asked questions
What is Dr. Michael Gibson's medical specialty?
Dr. Michael Gibson practices Interventional Pain Medicine Physician in Hoover, AL.
Where does Dr. Michael Gibson practice?
Dr. Michael Gibson practices at 4515 Southlake Pkwy Ste 200, Hoover, AL 352443319. Office phone: 2053137246.
What is Dr. Michael Gibson's NPI?
Dr. Michael Gibson's National Provider Identifier (NPI) is 1013068881, issued by NPPES.
Does Dr. Michael Gibson accept Medicare assignment?
Yes. Dr. Michael Gibson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Gibson commonly perform?
Top Medicare-reported procedures in 2023: Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Testing for presence of drug, by chemistry analyzers (HCPCS 80307); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.